BR9810021A - Derivados 9-oxima-eritromicina - Google Patents

Derivados 9-oxima-eritromicina

Info

Publication number
BR9810021A
BR9810021A BR9810021-1A BR9810021A BR9810021A BR 9810021 A BR9810021 A BR 9810021A BR 9810021 A BR9810021 A BR 9810021A BR 9810021 A BR9810021 A BR 9810021A
Authority
BR
Brazil
Prior art keywords
compounds
formula
oxime
erythromycin derivatives
methods
Prior art date
Application number
BR9810021-1A
Other languages
English (en)
Inventor
Young-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9810021A publication Critical patent/BR9810021A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS 9-OXIMA-ERITROMICINA"<D>. A invenção refere-se a compostos de fórmula I e aos seus sais farmaceuticamente aceitáveis, em que R¹, R², R^ 6^ e X são como aqui definidos. A invenção refere-se também às composições farmacêuticas que contêm os compostos de fórmula I, aos métodos para utilizar os referidos compostos de fórmula I no tratamento de infecções bacterianas e protozoárias, e aos métodos para preparar os referidos compostos de fórmula I.
BR9810021-1A 1997-06-11 1998-05-15 Derivados 9-oxima-eritromicina BR9810021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
BR9810021A true BR9810021A (pt) 2000-09-19

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810021-1A BR9810021A (pt) 1997-06-11 1998-05-15 Derivados 9-oxima-eritromicina

Country Status (31)

Country Link
EP (1) EP0988308A1 (pt)
JP (1) JP2000513026A (pt)
KR (1) KR20010013660A (pt)
CN (1) CN1259135A (pt)
AP (1) AP9801253A0 (pt)
AR (1) AR012244A1 (pt)
AU (1) AU7226798A (pt)
BG (1) BG103947A (pt)
BR (1) BR9810021A (pt)
CA (1) CA2293335A1 (pt)
CO (1) CO4940506A1 (pt)
CZ (1) CZ9904388A3 (pt)
EA (1) EA199901016A1 (pt)
GT (1) GT199800074A (pt)
HN (1) HN1998000073A (pt)
HR (1) HRP980316A2 (pt)
HU (1) HUP0002252A3 (pt)
ID (1) ID24529A (pt)
IL (1) IL132767A0 (pt)
IS (1) IS5251A (pt)
MA (1) MA26505A1 (pt)
NO (1) NO996108L (pt)
OA (1) OA11225A (pt)
PA (1) PA8451801A1 (pt)
PE (1) PE79899A1 (pt)
PL (1) PL337606A1 (pt)
TN (1) TNSN98083A1 (pt)
TR (1) TR199902995T2 (pt)
TW (1) TW448174B (pt)
WO (1) WO1998056800A1 (pt)
ZA (1) ZA985018B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
ATE298761T1 (de) 1998-09-22 2005-07-15 Pfizer Prod Inc Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
WO2000075156A1 (en) * 1999-06-07 2000-12-14 Abbott Laboratories 6-o-carbamate ketolide derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
TW448174B (en) 2001-08-01
KR20010013660A (ko) 2001-02-26
HN1998000073A (es) 1999-01-08
BG103947A (en) 2000-07-31
TNSN98083A1 (fr) 2005-03-15
NO996108L (no) 2000-02-10
PE79899A1 (es) 1999-08-25
AP9801253A0 (en) 1999-12-04
HUP0002252A3 (en) 2002-01-28
AR012244A1 (es) 2000-09-27
NO996108D0 (no) 1999-12-10
CA2293335A1 (en) 1998-12-17
CZ9904388A3 (cs) 2002-10-16
GT199800074A (es) 1999-11-27
EA199901016A1 (ru) 2000-06-26
ID24529A (id) 2000-07-20
IS5251A (is) 1999-11-16
EP0988308A1 (en) 2000-03-29
AU7226798A (en) 1998-12-30
HRP980316A2 (en) 1999-04-30
TR199902995T2 (xx) 2000-02-21
PA8451801A1 (es) 2000-05-24
PL337606A1 (en) 2000-08-28
HUP0002252A2 (hu) 2000-12-28
ZA985018B (en) 1999-12-10
IL132767A0 (en) 2001-03-19
OA11225A (en) 2003-07-17
JP2000513026A (ja) 2000-10-03
WO1998056800A1 (en) 1998-12-17
CO4940506A1 (es) 2000-07-24
MA26505A1 (fr) 2004-12-20
CN1259135A (zh) 2000-07-05

Similar Documents

Publication Publication Date Title
BR9810021A (pt) Derivados 9-oxima-eritromicina
BR9713552A (pt) Derivados de pirimidina bicìclicos condensados
EA199901015A1 (ru) 4&#34;-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0201437A (pt) Processo para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4&#34;-substituìdos&#34;
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BR0010938A (pt) Derivados da 13-metil eritromicina
BR9814592A (pt) &#34;compostos azopolicìclicos condensados com arila&#34;
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
BR0010746A (pt) Derivados heterocìclicos úteis com agentes anticâncer
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BR9810097A (pt) Derivados de macrolìdeos c-4-substituìdos
BR9709959A (pt) Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
BR9914998A (pt) Antibióticos macrólidos
BR9915480A (pt) Azalìdeos de 13 membros e a sua utilização como agentes antibióticos
BR9905089A (pt) Derivados macrolìdeos
AP9801377A0 (en) Tricyclic erythromycin derivatives.
BR0002505A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
BR0005496A (pt) Macrólidos
BR9910206A (pt) Derivados de higromicina a.
BR0006299A (pt) Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina
AP9801235A0 (en) Erythromycin derivatives.
BR0012329A (pt) Derivados de benzofurano
BR0015153A (pt) Derivados de higromicina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.